[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350294-105":59,"doc-detail-350294-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-loyalty-card-study-2-clocs-2-protocol-for-an-observational-case-control-study-focusing-on-the-patient-interval-in-cancer-diagnosis","Cancer loyalty card study-2 (CLOCS-2) - protocol for an observational case-control study focusing on the patient interval in cancer diagnosis","","Late cancer diagnosis reduces treatment options and outcomes. People with an undiagnosed cancer may self-manage nonspecific symptoms with over-the-counter medications that can mimic common, easily treated conditions. The Cancer Loyalty Card Study (CLOCS) suggests increased purchases of pain and indigestion medication 8–9 months before ovarian cancer. CLOCS-2 aims to validate whether significant medication-purchase changes indicate early signs across multiple cancer types using store loyalty card data.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-loyalty-card-study-2-clocs-2-protocol-for-an-observational-case-control-study-focusing-on-the-patient-interval-in-cancer-diagnosis/350294/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-loyalty-card-study-2-clocs-2-protocol-for-an-observational-case-control-study-focusing-on-the-patient-interval-in-cancer-diagnosis/350294.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does CLOCS-2 address?","Question",{"text":112,"@type":113},"CLOCS-2 targets late cancer diagnosis by examining whether medication purchasing patterns can signal early, often nonspecific, symptoms before a formal diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CLOCS-2 compare participants?",{"text":117,"@type":113},"It uses a retrospective case-control design comparing 1450 cancer cases with 1450 controls without cancer in the UK, all holding loyalty cards from participating retailers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancer types and what data sources are used?",{"text":121,"@type":113},"The study covers oesophageal, stomach (gastric), colorectal (bowel), pancreatic, liver, bladder, endometrial, uterine sarcoma, ovarian and vulval cancers, using pre-existing loyalty card purchase data and additional demographic, risk factor, lifestyle, family history, and symptom information.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350294,1791006244,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Open access Protocol  \n Cancer loyalty card study-2 (CLOCS-2):  \nprotocol for an observational casecontrol study focusing on the patient interval in cancer diagnosis  \nSima Toopchiani,1 Saphsa Codling,1 Yuscah Pondeca,1 Sandeep Kaur  ,1 Kevin Horeau,1,2 Hannah Brewer,1 Amanda Cross,3 Brendan Delaney,1 A Aldo Faisal,4 Christopher Peters,1 James Goulding,5 Yasemin Hirst,6 Sudha Sundar  ,7 James M Flanagan  1  \nTo cite: Toopchiani S, Codling S, Pondeca Y, et al. Cancer loyalty card study-2 (CLOCS-2):  \nprotocol for an observational case-control study focusing on the patient interval in cancer diagnosis. BMJ Open 2026;16:e117937 . doi:10 . 1136/ bmjopen-2026-117937  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2026-117937](bmjopen-2026-117937)) .  \nReceived 05 February 2026 Accepted 24 April 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. For numbered affiliations see end of article.  \nCorrespondence to  \nDr James M Flanagan; [j.flanagan@imperial.ac.uk](j.flanagan@imperial.ac.uk)  \nABSTRACT  \nIntroduction Some cancers are diagnosed late, making them harder to treat. People with an undiagnosed cancer may use over-the-counter medications to manage nonspecific cancer-related symptoms that often mimic other more common, easily treatable conditions. Results from the original Cancer Loyalty Card Study (CLOCS) suggest there may be an increase in purchases of pain and indigestion medication 8–9 months before an ovarian cancer diagnosis. We aim to validate the CLOCS findings by exploring whether a significant change in medication purchases could be an indication for early signs of the following cancer types: oesophageal, stomach (gastric), colorectal (bowel), pancreatic, liver, bladder, endometrial, uterine sarcoma, ovarian and vulval, using data collected through store loyalty cards.  \nMethods and analysis Using a retrospective case-control design, we aim to recruit 1450 participants with one of the cancers of interest (cases) and 1450 participants without cancer (controls) in the UK who (or whose household members) hold a loyalty card with at least one participating high street retailer. We will use pre-existing loyalty card data to compare past purchase patterns of cases with those of controls. To assess cancer risk in participants and their purchasing patterns, we will collect information on demographic characteristics, health risk factors, lifestyle habits and behaviours, family history of cancer and any symptoms experienced prior to diagnosis (cases) and in the last year prior to study recruitment (controls) . In addition, cases will be asked about their cancer diagnosis.  \nEthics and dissemination CLOCS-2 was reviewed and approved by the East Midlands-Leicester South Research Ethics Committee (23/EM/0224). Study outcomes will be disseminated through peer-reviewed publications, conferences, presentations to the research communities as well as patients and the public, the study website and other social media outlets.  \nTrial registration number NCT06447064, CPMS58679; pre-results.  \nINTRODUCTION  \nCancer is one of the leading causes of death worldwide, accounting for an estimated  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ A key strength is the use of longitudinal purchase data recorded up to 6 years prior to enrolment, enabling analysis of temporal patterns before diagnosis.  \n⇒ A further strength is the inclusion of multiple cancer types within a single study design, allowing comparison across groups.  \n⇒ A key limitation is the incomplete capture of purchasing behaviour due to inconsistent loyalty card use and transactions outside participating retailers.  \n⇒ Another limitation is the potential for exposure misclassification due to reliance on self-reported health survey data amon","cbCaih4gpz0g1xLY","https://ap.wps.com/l/cbCaih4gpz0g1xLY","pdf",1030720,"English","# Abstract\n# Introduction\n# Strengths and limitations of this study","[{\"question\":\"What problem does CLOCS-2 address?\",\"answer\":\"CLOCS-2 targets late cancer diagnosis by examining whether medication purchasing patterns can signal early, often nonspecific, symptoms before a formal diagnosis.\"},{\"question\":\"How does CLOCS-2 compare participants?\",\"answer\":\"It uses a retrospective case-control design comparing 1450 cancer cases with 1450 controls without cancer in the UK, all holding loyalty cards from participating retailers.\"},{\"question\":\"Which cancer types and what data sources are used?\",\"answer\":\"The study covers oesophageal, stomach (gastric), colorectal (bowel), pancreatic, liver, bladder, endometrial, uterine sarcoma, ovarian and vulval cancers, using pre-existing loyalty card purchase data and additional demographic, risk factor, lifestyle, family history, and symptom information.\"}]","Cancer loyalty card study-2 (CLOCS-2) - protocol for an observational case-control study focusing on the patient interval in cancer diagnosis | PDF",1790088277,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f862b8a524344560fbb84d2c1e99af7e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/441731c375376bcc74611c07ad6668cc.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4077a9e076a1fcad3d354dbae4a4b36.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe2549651daba6774f38e14e059d0f52.webp",980,1306]